Bodevet

About Bodevet

This author has not yet filled in any details.
So far Bodevet has created 22 blog entries.

Trehalose lyophilized platelets for wound healing

Authors: Giorgio Pietramaggiori, MD; Arja Kaipainen, MD, PhD; David Ho, PhD; Cindy Orser, PhD; Walter Pebley, PE; Alan Rudolph, PhD, MBA; Dennis P. Orgill, MD, PhD Abstract: Fresh platelet preparations are utilized to treat a wide variety of wounds, although storage limitations and mixed results have hampered their clinical use. We hypothesized that concentrated lyophilized [...]

By |2019-07-17T18:07:57+00:00May 8th, 2019|Research|0 Comments

Single Dose Toxicity Study Of Canine Thrombosomes™ In Dogs Followed By A 14-Day Observation Period

Study Director: Jonathan C. White, M.S.A. Abstract: This study was conducted for Cellphire, Inc., to evaluate the safety of the test article, Canine Thrombosomes™, following a single infusion dose of 10x the native platelet protein per animal (10x) or 3 doses of 1x the native platelet protein per animal (3x). Two treatment groups of six [...]

By |2019-07-17T18:08:13+00:00May 8th, 2019|Research|0 Comments

Clinical Development of Stabilized Platelets for In-fusible Clinical Applications

Investigator: William T. Phillips, MD Co-Investigators: Vibhudutta Awasthi, PhD and Beth Goins, PhD Abstract: To study the circulation kinetics of freeze-dried platelets (FDP) in normal rabbits and to investigate the effect of re-injection of human freeze-dried platelets (thrombosomes). There were no observed differences in accumulation of endogenous platelets and FDPs in other tissues. It is [...]

By |2019-07-17T18:46:08+00:00May 8th, 2019|Research|0 Comments

BodeVet Clinical Trial Update 1-2017-K9

1-2017-K9 is a multicenter, randomized clinical safety and efficacy study to evaluate the safety and efficacy of StablePlate RX® in clinical canine patients for the control of life threatening hemorrhage secondary to thrombocytopenia. For more information please contact BodeVet. For more information, click here.

By |2019-07-19T11:23:25+00:00February 1st, 2018|News|0 Comments

Elephant disease causes death by hemorrhage… Lyophilized platelets may help.

The in-human care population of elephants is plagued by an endotheliotropic herpes virus that attacks young elephants and causes an acute loss of platelets with associated bleeding.  BodeVet, Inc. working with the Smithsonian Institute has begun the process of producing lyophilized platelets for zoos to have available when bleeding occurs.  A clinical trial is proposed [...]

By |2019-07-20T10:27:55+00:00February 1st, 2018|News|0 Comments

BodeVet CTO to Present at IVECCS 2017

BodeVet Chief Technical officer, Anne Hale, DVM, will advise on controversies in blood banking at the International Veterinary Emergency and Critical Care Symposium (IVECCS) 2017. As a recognized world leader in veterinary blood banking, Anne Hale joins a selection of other experts for a panel discussion. This discussion is open to all IVECCS attendees and takes place at 4:15 [...]

By |2019-07-19T11:23:25+00:00August 10th, 2017|News|0 Comments

StablePlate RX™ Launching in September at IVECCS 2017

This September, the world’s first injectable freeze-dried platelet derived product will be StablePlate RX™ for canines. StablePlate RX™ is a shelf stable hemostatic agent that couples the healing power of platelets with the stability and convenience of other medicines. BodeVet will release StablePlate RX™ on a limited basis at the International Veterinary and Critical Care Symposium (IVECCS). Visit BodeVet at [...]

By |2019-07-19T11:23:25+00:00August 8th, 2017|News|0 Comments

Parent Company Cellphire Awarded Grant to Develop Elephant Endotheliotropic Herpesvirus (EEHV) Treatment

Thanks to a grant from the International Elephant Foundation, biotechnology company Cellphire, Smithsonian Global Health Program, Ringling Bros. Center for Elephant Conservation, Fort Worth Zoo, and Houston Zoo have made great strides in developing a novel treatment for a lethal virus afflicting baby Asian elephants around the globe. Elephant Endotheliotropic Herpesvirus (EEHV) is the leading [...]

By |2019-07-19T11:23:25+00:00July 20th, 2017|News|0 Comments

1-2017-K9 Trial for StablePlate RX™ Begins

The 1-2017-K9 trial for StablePlate RX™ is underway. StablePlate RX™ is being evaluated in canines with life-threatening bleeding secondary to thrombocytopenia. Safety and efficacy results are anticipated in fall 2017. BodeVet is working with top veterinarians at academic and private hospitals to advance the standard of care for veterinary patients. StablePlate RX™ stands to revolutionize [...]

By |2019-07-19T11:23:25+00:00May 2nd, 2017|News|0 Comments
Call Now Button